CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma

Overview of attention for article published in Frontiers in immunology, August 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 29 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 34,305 followers.

RT @FrontImmunol: New Research: CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinom…

31 Aug 2021

Reply Repost Favourite

RT @FrontImmunol: New Research: CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinom…

31 Aug 2021

Reply Repost Favourite

RT @FrontImmunol: New Research: CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinom…

31 Aug 2021

Reply Repost Favourite

New Research: CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma: Intrahepatic cholangiocarcinoma (ICC) is highly invasive and carries high mortality due to limited therapeutic… https://t.co/DXD1J6m

31 Aug 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.